Danon disease in women: a modern view of the problem: a case series

Danon disease in women: a modern view of the problem: a case series

Introduction. Danon disease is a rare cardiomyopathy (CMP) with multisystem involvement, which is associated with lysosome-associated membrane protein 2 (LAMP2) gene polymorphisms. This protein is the most important regulator of autophagy and is produced mainly in the myocardium, skeletal muscles an...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. P. Myasnikov, D. A. Nefedova, N. N. Kuzina, O. V. Kulikova, E. V. Gagarina, E. A. Mershina, O. M. Drapkina
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2024-12-01
Series:	Российский кардиологический журнал
Subjects:	danon disease lamp2 women storage disease cardiomyopathy hypertrophic cardiomyopathy heart failure arrhythmia atrial fibrillation ventricular tachycardia cardiac fibrosis sudden cardiac death
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/6142
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

DANON DISEASE: A RARE SYSTEMIC DISORDER WITH THE LAMP2-CARDIOMYOPATHY
by: T. G. Vaykhanskaya, et al.
Published: (2017-11-01)

Cardiomyopathy with Restrictive-Hypertrophic Phenotype and Initial Morphological Diagnosis “Amyloidosis” as a Manifestation of Danon Disease in a Woman
by: O. V. Blagova, et al.
Published: (2020-05-01)

<i>MYBPC3</i>-associated cardiomyopathy: features of the course and prospects for specific therapy
by: D. A. Nefedova, et al.
Published: (2025-02-01)

Desmoplakin and features of desmoplakin cardiomyopathy
by: R. P. Myasnikov, et al.
Published: (2023-11-01)

Eurasian association of cardiology (EAC) guidelines for the prevention and treatment of ventricular heart rhythm disorders and prevention of sudden cardiac death (2022)
by: S. P. Golitsyn, et al.
Published: (2022-12-01)

Natural history and clinical outcomes of patients with hypertrophic cardiomyopathy from thin filament mutations
by: Tatiana Saul, et al.
Published: (2024-12-01)

The clinical use of the MOGE(S) classification in the differential diagnosis between idiopathic hypertrophic cardiomyopathy and its phenocopies
by: A. Poliakova, et al.
Published: (2019-11-01)

A novel SCN5A variant causing Brugada syndrome: a case of Slovenian family
by: Karin Writzl, et al.
Published: (2025-04-01)

An International Longitudinal Natural History Study of Patients With Danon Disease: Unique Cardiac Trajectories Identified Based on Sex and Heart Failure Outcomes
by: Kimberly N. Hong, et al.
Published: (2025-04-01)

Electrocardiographic parameters and features of ventricular arrhythmias in various arrhythmogenic cardiomyopathy forms in the pediatric population: a systematic review and meta-analysis
by: D. Yu. Alekseeva, et al.
Published: (2022-09-01)

SUDDEN DEATH IN HYPERTROPHIC CARDIOMYOPATHY: SEARCH FOR NEW RISK FACTORS
by: N. S. Krylova, et al.
Published: (2017-02-01)

Right ventricular dysfunction improves prediction of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance study
by: Shengxu Li, et al.
Published: (2025-06-01)

DX single-lead implantable cardioverter-defibrillator system with a floating atrial dipole: when, to whom, and why?
by: A. V. Prokopenko, et al.
Published: (2023-06-01)

Shortened PQ interval in the differential diagnosis of Anderson-Fabry disease: a case report
by: P. D. Zlobina, et al.
Published: (2022-08-01)

NEUROTROPIC MYOCARDIAL SCINTIGRAPHY IN THE EVALUATION OF SUDDEN CARDIAC DEATH PROGNOSIS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: A. A. Ansheles, et al.
Published: (2017-09-01)

Prognostic value of morphological, biochemical, molecular markers of fibrosis in patients with hypertrophic cardiomyopathy
by: G. A. Burnasheva, et al.
Published: (2023-12-01)

Incidence and prognostic significance of atrial fibrillation in patients with tako-tsubo syndrome-systematic review and meta-analysis.
by: Andrzej Osiecki, et al.
Published: (2025-06-01)

The Effect of Coronary Artery Disease on the Prognosis of Hypertrophic Cardiomyopathy: A Multi-Center Cohort Study
by: Guoqing Hou, et al.
Published: (2025-01-01)

A new prediction model for sustained ventricular tachycardia in arrhythmogenic cardiomyopathy
by: Baowei Zhang, et al.
Published: (2024-12-01)

SUDDEN CARDIAC DEATH: ETIOLOGICY IN PATIENTS OF DIFFERENT AGES, RISK FACTORS AND PREVENTION
by: O. V. Gaisenok
Published: (2016-01-01)

2020 Clinical practice guidelines for Hypertrophic cardiomyopathy
by: S. A. Gabrusenko, et al.
Published: (2021-06-01)

Validation of ACC/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study
by: Murillo Oliveira Antunes, et al.
Published: (2024-12-01)

CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
by: E. V. Privalova, et al.
Published: (2013-02-01)

Pediatric arrhythmias: a comprehensive integrative review, symptom-based conceptual framework, and practical care guide
by: Ana C. Cepeda-Nieto, et al.
Published: (2025-04-01)

Interdisciplinary approach to surgical treatment for patients with hypertrophic obstructive cardiomyopathy
by: K. V. Rudenko, et al.
Published: (2021-07-01)

Cardiac phenotype of Fabry Disease
by: M. S. Kharlap, et al.
Published: (2018-08-01)

Prevalence of myocarditis and its contribution to the course of primary myocardial hypertrophy
by: Yu. A. Lutokhina, et al.
Published: (2023-11-01)

INFLUENCE OF THE POLYMORPHISM OF THE RENIN-ANGIOTENSIN SYSTEM GENES ON THE CARDIAC ARRHYTHMIAS IN CHILDREN WITH HYPERTROPHIC CARDIOMYOPATHY
by: N. A. Berezneva, et al.
Published: (2013-05-01)

“Muscle Bridge” as a Possible Risk Factor for Sudden Cardiac Death in a Child with Hypertrophic Cardiomyopathy: Case Study
by: Larisa A. Balykova, et al.
Published: (2025-07-01)

Atrial Fibrillation in Hypertrophic Cardiomyopathy
by: G. A. Ignatenko, et al.
Published: (2021-05-01)

Deceleration and acceleration capacities of heart rate in patients with hypertrophic cardiomyopathy: results of a five-year prospective study
by: D. A. Tsaregorodtsev, et al.
Published: (2022-08-01)

Hypertrophic Cardiomyopathy with Special Focus on Mavacamten and Its Future in Cardiology
by: Ewelina Młynarska, et al.
Published: (2024-11-01)

DES GENE MUTATION IN A FAMILY OF PROBAND WITH MYOFIBRILLARY MYOPATHY AND NON-COMPACTION CARDIOMYOPATHY, RESULTED IN CARDIAC TRANSPLANTATION
by: R. P. Myasnikov, et al.
Published: (2017-11-01)

The combination of left ventricular non-compaction and hypertrophic cardiomyopathy in one family with a pathogenic variant in the MYBPC3 gene (rs397516037)
by: R. P. Myasnikov, et al.
Published: (2020-11-01)

Clinical variants, outcomes and prognosis of hypertrophic non-obstructive cardiomyopathy: results of long-term follow-up
by: D. V. Bogdanov, et al.
Published: (2019-11-01)

Developing a risk prediction model for sudden cardiac death in children with hypertrophic cardiomyopathy
by: Zhen Zhen, et al.
Published: (2025-08-01)

Prognosis of pulmonary hypertension in patients with hypertrophic cardiomyopathy: A multicenter propensity score matching study
by: Huihui Ma, et al.
Published: (2025-02-01)

IF SYNUS RHYTHM RESTORATION IMPACTS EFFICIENCY OF CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH SEVERE CARDIAC INSUFFICIENCY AND CONSTANT ATRIAL FIBBRILATION
by: D. I. Lebedev, et al.
Published: (2019-02-01)

Utility of Cardiac Computed Tomography in the Diagnosis of Apical Hypertrophic Cardiomyopathy: A Case Series
by: Dinkar Bhasin, et al.
Published: (2024-10-01)

Age and Sex Differences in the Risk of Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy: A Multi-Centre Cohort Study
by: Ma H, et al.
Published: (2025-04-01)